News | News By Subject | News by Disease News By Date | Search News

Bladder cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Sanofi Pasteur (SASY.PA) Abandons Bladder Cancer Drug     11/18/2016
Study Stopped Early as Merck & Co. (MRK)'s Immunotherapy Drug Wows in Bladder Cancer Trial     10/27/2016
Spectrum Pharma (SPPI) Allegedly Hid a Key Detail From a Meeting With the FDA     9/19/2016
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation     6/28/2016
ASCO2016: Genentech (RHHBY)'s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer     6/6/2016
Genentech (RHHBY) Nabs FDA Approval of First New Bladder Cancer Drug in 30 Years     5/20/2016
Roche (RHHBY)'s Pharma Head Believes Its First Cancer Immunotherapy Will Win FDA Approval Soon     4/19/2016
Genentech (RHHBY)'s Bladder Cancer Drug Gains Priority Review by the FDA     3/16/2016
AstraZeneca PLC (AZN) Continues Its Immuno-Oncology Roll, Durvalumab Gets Breathrough Designation for Bladder Cancer     2/18/2016
FDA Lifts Heat Biologics Partial Clinical Hold     2/10/2016
Roche (RHHBY) Encouraged by Mid-Stage Atezolizumab Bladder Cancer Data     1/8/2016
Merck KGaA (MKGAF.PK), Pfizer (PFE) Accelerate Immuno-Oncology Drug Avelumab into Phase III Ovarian and Bladder Cancer Trials     12/22/2015
FDA Panel Rejects Telesta (TSX:TST)'s Bladder Cancer Drug MCNA     11/19/2015
Telesta (TSX:TST), Ipsen (IPN.PA) Strike $137 Million+ Bladder Cancer Pact     10/28/2015
Telesta (TSX:TST) Sets Up U.S. Ops in Anticipation of Approval of Bladder Cancer Drug MCNA     9/15/2015

News from Around the Web
Coroner Alarmed By Lack Of Warning On Pfizer (PFE) Drug Champix     11/21/2016
Mycobacterium In Olive Oil For Cancer Treatment, Universitat Autònoma de Barcelona Study     6/23/2016
Newcastle University Study Could Lead To Approval Of Test For Bladder Cancer     1/18/2016
No Link Found Between Bladder Cancer And Popular Diabetes Meds, University of Dundee Study     12/8/2014
Source Of Most Cases Of Invasive Bladder Cancer Identified, Stanford University School of Medicine Study     4/22/2014
Three of Four Cases of Bladder Cancer Display Mutations in the Same Gene, National Cancer Research Centre Study     9/11/2013
High Levels of Vitamin D in Plasma Protects Against Bladder Cancer, Spanish National Cancer Research Centre Study     10/31/2012
Selenium May Protect Against Bladder Cancer, Study Published in Cancer Epidemiology, Biomarkers & Prevention     9/1/2010
Well-Done Meat Doubles Bladder Cancer Risk, University of Texas Study     4/20/2010
Variation In Prostate Stem Cell Antigen Gene Raises Bladder Cancer Risk, University of Texas MD Anderson Cancer Center Study     8/20/2009
Intensive Early Treatment Doesn't Help Bladder Cancer Survival, University of Michigan Health System Study     4/8/2009
Frankincense Oil 'Could Be Alternative Treatment For Bladder Cancer', University of Oklahoma Study     3/19/2009
Investigational Treatment for Deadly Bladder Cancer, Developed Using New Research Model, by Columbia University Medical Center Faculty-Led Team     3/19/2009
Selenium May Prevent High Risk-Bladder Cancer, Dartmouth Medical School Study     12/8/2008
Yoghurt Can Benefit Bladder Cancer, Say Karolinska Institute Researchers     10/21/2008

Press Releases
Heat Biologics Presents Topline HS-410 Phase II Bladder Cancer Results At The Society Of Urological Oncology Annual Meeting     12/1/2016
Spectrum Pharma (SPPI) Plays With a New Phase III Concept After the FDA Formally Spurns Bladder Cancer Drug     11/18/2016
Heat Biologics To Present Topline HS-410 Phase II Bladder Cancer Results At The Society Of Urological Oncology Annual Meeting     11/16/2016
Merck & Co. (MRK)’s KEYTRUDA (pembrolizumab) Significantly Improves Overall Survival Compared To Chemotherapy In Previously Treated Patients with Advanced Bladder (Urothelial) Cancer     11/14/2016
Bristol-Myers Squibb (BMY) Release: Opdivo (Nivolumab) And Yervoy (Ipilimumab) Regimen Shows Promising Efficacy And Safety In Previously Treated Patients With Advanced Form Of Bladder Cancer     11/14/2016
OncoGenex (OGXI) Announces Positive Survival Results From Apatorsen Phase 2 Borealis-2 Trial In Metastatic Bladder Cancer     10/26/2016
NYU Langone Medical Center Release: Treatment Shrinks Bladder Cancer Tumors In Patients That Can't Tolerate Chemotherapy     10/11/2016
PapGene, Inc. Awarded NIH Contract For The Surveillance Of Recurrent Bladder Cancer     9/27/2016
Xcell Biosciences Initiates New Collaborations With UCSF Researchers Studying Effectiveness Of Immunotherapy In Urologic Cancers     9/22/2016
FDA Panel Votes Against Spectrum Pharma (SPPI)'s Bladder Cancer Drug     9/14/2016
Biocept, Inc. (BIOC) To Collaborate With Renowned Clinical Investigator Dr. Shilpa Gupta To Study The Utility Of Liquid Biopsy Testing In Bladder And Prostate Cancers     9/9/2016
TARIS Biomedical Launches Second Phase 1b Clinical Trial Of TAR-200 (Gemris) In Patients With Bladder Cancer     8/10/2016
Signostics Initiates U.S. Commercial Launch Of Uscan, A Breakthrough In Bladder Care     8/5/2016
Seattle Genetics (SGEN) Reports Second Quarter 2016 Financial Results     7/27/2016
TARIS Biomedical Initiates Phase Ib Clinical Trial Of TAR-200 (Gemris™) In Patients With Muscle-Invasive Bladder Cancer     7/13/2016

//-->